Meeting
2023 ASCO Quality Care Symposium
Rates of surgery and adjuvant chemotherapy use in patients with stage IB to IIIA non-small cell lung cancer: A provincial population-based study.
Authors
Yuchen Li
Department of Oncology, Juravinski Cancer Centre, Hamilton, ON, Canada
Yuchen Li, Gregory Russell Pond, Yaron Shargall, Housne Begum, Daniel Goldshtein, Rosalyn A. Juergens
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care
Sub Track
Access to Treatment
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 134)
DOI
10.1200/OP.2023.19.11_suppl.134
Abstract #
134
Poster Bd #
C11
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Dynamic monitoring circulating tumor DNA in plasma samples by PEAC technology for patients with early-stage non–small cell lung cancer after surgery.
First Author: Ning Li
Poster
2019 ASCO Annual Meeting
Impact of timing of lung resection on survival for clinical stage I and II lung cancer.
First Author: Isabel M Emmerick
Poster
2015 ASCO Annual Meeting
Determinants for no definitive therapy for early-stage non-small cell lung cancer in U.S. population.
First Author: Yu-Wei Chen
Poster
2011 ASCO Annual Meeting
Outcomes of stereotactic body radiotherapy in patients with clinical stage I non-small cell lung cancer who are fit to undergo surgery.
First Author: S. Senan